A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis.
Small WC, DeSimone-Macchi D, Parker JR, Sukerkar A, Hahn PF, Rubin DL, Zelch JV, Kuhlman JE, Outwater EK, Weinreb JC, Brown JJ, de Lange EE, Woodward PJ, Arildsen R, Foster GS, Runge VM, Aisen AM, Muroff LR, Thoeni RF, Parisky YR, Tanenbaum LN, Totterman S, Herfkens RJ, Knudsen J, Bernardino ME, et al.
Small WC, et al. Among authors: woodward pj.
J Magn Reson Imaging. 1999 Jul;10(1):15-24. doi: 10.1002/(sici)1522-2586(199907)10:1<15::aid-jmri3>3.0.co;2-x.
J Magn Reson Imaging. 1999.
PMID: 10398973
Clinical Trial.